Inpart Logo
Campaign Preview

Feed Additive Approaches to Improve Fat and Protein Content in Cow's Milk

Closed

Opportunity types being sought:

Spinout Companies
Research Projects
Centres of Excellence
Academic Profiles
Technologies
Header

Novus International, Inc., a global leader in health and nutrition solutions for the animal agricultural industry, is seeking additive-based solutions to increase the content of fat and protein in milk. Solutions should be practical, scalable, low cost and efficacious.

Approaches of Interest:

  • Solutions should be a stable product or combination
  • Opportunities relating to modification of the animal microbiome, with a focus on direct‑fed microbials
  • Novel direct‑fed microbials, enzymes and small molecules affecting fat and protein metabolism and leading to improvements in milk fat and protein

Out of Scope:

  • Opportunities based on improving feed quality, increasing caloric value of feed or changing the physical properties of feed 
  • Research related to animal genetics
  • Compounds that are known to present registration challenges

Developmental Stages of Interest:

  • Submissions preferably should have proof-of-concept based on animal studies. Those between TRL3 and TRL6 will be prioritized
  • In-vivo data are preferred, however opportunities that provide in-vitro data and scientific basis behind the concept will also be considered

Submission Information

Submission of one-page, 200–300-word briefs is encouraged, along with any optional supplementary information e.g. relevant publications. Novus International, Inc., is also open to novel research proposals which can be outlined using this submission form. This campaign is also open to submissions from SMEs and startup companies. In submitting to this campaign, you confirm that your submission contains only non-confidential information. 

Opportunity for Collaboration

Our client is open to a range of collaboration opportunities, with the most appropriate outcome being decided on a case-by-case basis. Example outcomes include licensing assets, project/PhD funding, and research collaborations.